Atlas Trials

A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer

Clinical trial NCT02967133 · TERMINATED

Trial details

NCT number
NCT02967133
Sponsor
Alliance Foundation Trials, LLC.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer MetastaticNon-Small Cell Carcinoma of Lung, TNM Stage 4Nonsmall Cell Lung CancerNon Small Cell Lung Cancer Recurrent
Start date
2016-12-01
Primary completion
2018-01-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.